A Study to Assess the Relative Bioavailability of Oral Tavapadon in Healthy Adult Participants

Study Identifier
M25-974
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Healthy Volunteer
  • Study Drug
  • Tavapadon
  • Phase
    Phase 1
    Sex
    Female & Male
    Age
    18 - 55 Years

    Protocol Summary

    This study will assess the relative bioavailability of two different Oral formulations of tavapadon in healthy adult participants.

    Study Locations

    Location
    Status
    Location
    Acpru /Id# 275870
    Grayslake, Illinois, United States, 60030
    Status
    Not applicable